Ascentage Pharma Group International (AAPG) Leases (2023 - 2025)

Ascentage Pharma Group International (AAPG) has 3 years of Leases data on file, last reported at $6.7 million in Q4 2025.

• For the quarter ending Q4 2025, Leases fell 13.67% year-over-year to $6.7 million; the trailing twelve-month figure through Dec 2025 stood at $6.7 million (down 13.67% YoY), and the FY2025 full-year result was $6.8 million, down 11.03% from the prior year.
• Leases for Q4 2025 stood at $6.7 million, down from $7.1 million in the prior quarter.
• Across five years, Leases topped out at $7.8 million in Q4 2024 and bottomed at $6.7 million in Q4 2025.
• The 3-year median for Leases is $7.1 million (2023), against an average of $7.2 million.
• The widest annual swing landed in 2024, when Leases rose 9.74%; it then fell 13.67% in 2025.
• A 3-year view of Leases shows it stood at $7.1 million in 2023, then gained by 9.74% to $7.8 million in 2024, then retreated by 13.67% to $6.7 million in 2025.
• The last three Leases figures came in at $6.7 million (Q4 2025), $7.1 million (Q2 2025), and $7.8 million (Q4 2024), per Business Quant data.

Peer Comparison